NCT06164145

Brief Summary

The type of the study is an observational study to test in stroke survivors. The main questions it aims to answer are

  1. 1.What is a Burmese version, content validity, convergent validity, divergent validity, and reliability of SF-36 questionnaire in stroke survivors?
  2. 2.Does the Burmese version of SF-36 have the responsiveness in stroke survivors? Participants will be interviewed the questionnaire by the research team.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
125

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Dec 2023

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 1, 2023

Completed
10 days until next milestone

First Posted

Study publicly available on registry

December 11, 2023

Completed
19 days until next milestone

Study Start

First participant enrolled

December 30, 2023

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

March 6, 2024

Status Verified

March 1, 2024

Enrollment Period

1 year

First QC Date

December 1, 2023

Last Update Submit

March 4, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • Short Form 36

    Short Form 36 (SF-36) is a generic self-reported outcome measure that quantifies the quality of life in relation to health status. It is a 36-item valid and reliable evaluation with eight areas covering physical functioning, role limitations brought on by physical issues, bodily pain, general health perceptions, vitality, social functioning, role limitations brought on by emotional issues, and perceived mental health. The SF-36 also contains a single question called "health transition" that measures how respondents feel their over health status has changed over the course of a year. The scores range from 0-100 (the worst possible to the most possible) (Ware \& Sherbourne, 1992).

    Baseline-1 week-4th week

Secondary Outcomes (4)

  • Patient Reported Outcome Measurement System (PROMIS-29)

    Baseline-1 week

  • Berg Balance Scale (BBS)

    Baseline-1 week

  • Barthel Index (BI)

    Baseline-1 week

  • Global Rating of Change (GRC) Scale

    Baseline-1 week-4th week

Study Arms (1)

patients with hemiplegia

The intervention program will be based on usual care physiotherapy treatment in a hospital setting. It will be given 3 times per day, 5 days per week for 4 weeks duration.

Other: Usual care

Interventions

The training program used in this study is the stroke rehabilitation program focusing on health education for stroke and a routine exercise program based on the National Strategic Plan for Stroke Rehabilitation in Myanmar.

patients with hemiplegia

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Hemiplegic patients who will be treated at inpatient ward of Department of Physical Medicine and Rehabilitation

You may qualify if:

  • Age 18 years and above (Coppers et al., 2021; Soto-Vidal et al., 2021; Wayessa et al., 2023)
  • Hemiplegia induced by both ischemic and hemorrhagic stroke at least 1 month duration (Wayessa et al., 2023; Vincent-Onabajo, Owolabi \& Hamzat, 2014)
  • Ability to understand the study and respond to questions (on the Mini- Mental State Examination \> 23) (Wongchaisuwan et al., 2005; Muangpaisan et al., 2015)
  • Stable medical conditions

You may not qualify if:

  • Other neurological diseases such as Parkinson's disease, dementia, Alzheimer's disease, peripheral neuropathy according to medical history and record
  • Recurrent stroke
  • Participants with dysphasia, intellectual impairments, traumatic head injury, and psychiatric diseases (Wayessa et al., 2023)
  • \) Participants who cannot understand Burmese language

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yangon General Hospital

Yangon, 11131, Burma

RECRUITING

MeSH Terms

Conditions

Patient Satisfaction

Condition Hierarchy (Ancestors)

Treatment Adherence and ComplianceHealth BehaviorBehavior

Study Officials

  • Myitzu Khin Khin, Master

    Khon Kaen University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Myitzu Khin Khin, Master

CONTACT

Sawitri Wanpen, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

December 1, 2023

First Posted

December 11, 2023

Study Start

December 30, 2023

Primary Completion

December 30, 2024

Study Completion

December 30, 2024

Last Updated

March 6, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will share

IPD and documents will be available for sharing 1 year after publication for a period of 2 years. Access to the IPD and documents will be open on the IPDShare website with registration.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
1 year after publication

Locations